These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34001537)

  • 1. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice.
    Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J
    Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
    Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.
    Mantelli S; Jungo KT; Rozsnyai Z; Reeve E; Luymes CH; Poortvliet RKE; Chiolero A; Rodondi N; Gussekloo J; Streit S
    BMC Fam Pract; 2018 Oct; 19(1):169. PubMed ID: 30314468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study.
    van Middelaar T; Ivens SD; van Peet PG; Poortvliet RKE; Richard E; Pols AJ; Moll van Charante EP
    BMJ Open; 2018 Apr; 8(4):e020871. PubMed ID: 29678989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.
    Gillespie R; Mullan J; Harrison L
    Health Soc Care Community; 2022 Nov; 30(6):e6206-e6216. PubMed ID: 36165345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
    Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
    BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing for older adults in Australia: factors influencing GPs.
    Gillespie R; Mullan J; Harrison L
    Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Older Adult Health Literacy in the Day-to-Day Management of Polypharmacy and Making Decisions About Deprescribing: A Mixed Methods Study.
    Gillespie R; Mullan J; Harrison L
    Health Lit Res Pract; 2023 Jan; 7(1):e14-e25. PubMed ID: 36629783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of GP perspectives on deprescribing antidepressants: a qualitative study.
    Kelly D; Graffi J; Noonan M; Green P; McFarland J; Hayes P; Glynn L
    BMJ Open; 2021 Apr; 11(4):e046054. PubMed ID: 33820792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial.
    Jungo KT; Meier R; Valeri F; Schwab N; Schneider C; Reeve E; Spruit M; Schwenkglenks M; Rodondi N; Streit S
    BMC Fam Pract; 2021 Jun; 22(1):123. PubMed ID: 34157981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MediQuit - an electronic deprescribing tool: a pilot study in German primary care; GPs' and patients' perspectives.
    Michiels-Corsten M; Gerlach N; Junius-Walker U; Schleef T; Donner-Banzhoff N; Viniol A
    BMC Prim Care; 2022 Sep; 23(1):252. PubMed ID: 36162994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.
    Schuling J; Gebben H; Veehof LJ; Haaijer-Ruskamp FM
    BMC Fam Pract; 2012 Jul; 13():56. PubMed ID: 22697490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice.
    Junius-Walker U; Viniol A; Michiels-Corsten M; Gerlach N; Donner-Banzhoff N; Schleef T
    Drugs Aging; 2021 Aug; 38(8):725-733. PubMed ID: 34251594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices.
    Hassan D; Versmissen J; Hek K; van Dijk L; van den Bemt PMLA
    BMC Prim Care; 2022 Nov; 23(1):280. PubMed ID: 36352363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.